
Current Price | $72.59 | Mkt Cap | $225.0B |
---|---|---|---|
Open | $72.92 | P/E Ratio | 47.80 |
Prev. Close | $72.59 | Div. (Yield) | $1.45 (2.0%) |
Daily Range | $72.57 - $73.42 | Volume | 8,040,709 |
52-Wk Range | $52.65 - $76.56 | Avg. Daily Vol. | 4,126,699 |
The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.
Current Price | $72.59 | Mkt Cap | $225.0B |
---|---|---|---|
Open | $72.92 | P/E Ratio | 47.80 |
Prev. Close | $72.59 | Div. (Yield) | $1.45 (2.0%) |
Daily Range | $72.57 - $73.42 | Volume | 8,040,709 |
52-Wk Range | $52.65 - $76.56 | Avg. Daily Vol. | 4,126,699 |
The best Bull and Bear pitches based on recency and number of recommendations.
AstraZeneca is primed to expand its presence within the huge and growing orphan drug market, expand its market share in China's oncology market via its new indication for Imfinzi, and the stock is trading at a discount to fair value.
I like the MedImmune acquisition but their balance sheet looks like crap- 5billion in cash vs 15billion in debt, plus negative earnings and revenue. Think it will take some time before the MedImmune acquisition starts to pay off
Read the most recent pitches from players about AZN.
Recs
AstraZeneca is primed to expand its presence within the huge and growing orphan drug market, expand its market share in China's oncology market via its new indication for Imfinzi, and the stock is trading at a discount to fair value.
Recs
Revenue growth and Profit margins.
Recs
Promising COVID-19 vaccine in development by EoY.
Find the members with the highest scoring picks in AZN.
timjake (25.84) Score: +386.57
The Score Leader is the player with the highest score across all their picks in AZN.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
timjake | 25.84 | 3/17/2008 |
![]() |
NS | $9.84 | +639.18% | +252.61% | +386.57 | 1 Comment | |
equalfuture | 24.63 | 3/18/2008 |
![]() |
1Y | $10.16 | +616.50% | +241.69% | +374.81 | 1 Comment | |
snickers4niki | 73.88 | 3/28/2008 |
![]() |
NS | $10.31 | +605.57% | +233.93% | +371.65 | 0 Comment | |
oferm | 36.25 | 3/19/2008 |
![]() |
3W | $10.35 | +603.10% | +232.71% | +370.39 | 0 Comment | |
gallo19 | 75.63 | 3/14/2008 |
![]() |
NS | $10.26 | +609.43% | +244.20% | +365.23 | 0 Comment | |
IMakeItRain | 88.29 | 3/14/2008 |
![]() |
3Y | $10.39 | +600.62% | +236.14% | +364.48 | 0 Comment | |
Ramhorn | < 20 | 3/14/2008 |
![]() |
NS | $10.39 | +600.62% | +236.14% | +364.48 | 0 Comment | |
b400 | 99.31 | 3/5/2008 |
![]() |
5Y | $10.46 | +595.74% | +232.76% | +362.99 | 0 Comment | |
floridabull33 | 85.73 | 3/27/2008 |
![]() |
3M | $10.48 | +594.43% | +233.09% | +361.34 | 1 Comment | |
EpicAhab | 32.91 | 2/12/2008 |
![]() |
5Y | $10.57 | +588.34% | +230.81% | +357.52 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.